These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1848153)

  • 1. Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy.
    Rosner D; Lane WW; Penetrante R
    Cancer; 1991 Mar; 67(6):1498-503. PubMed ID: 1848153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study.
    Li Y; Zhang S; Wei X; Zhang J
    Int J Surg; 2015 Jul; 19():91-4. PubMed ID: 26013173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer.
    Wong JH; Kopald KH; Morton DL
    Arch Surg; 1990 Oct; 125(10):1298-301; discussion 1301-2. PubMed ID: 2171453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and survival of female patients with nonpalpable breast carcinoma.
    Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
    Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of ductal carcinoma in situ of the breast. 10- to 20-year follow-up.
    Simpson T; Thirlby RC; Dail DH
    Arch Surg; 1992 Apr; 127(4):468-72. PubMed ID: 1313671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.
    Hardman PD; Worth A; Lee U; Baird RM
    Can J Surg; 1989 Jan; 32(1):56-60. PubMed ID: 2535949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.
    Parikh RR; Haffty BG; Lannin D; Moran MS
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):7-13. PubMed ID: 20950955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].
    Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B
    Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary staging in ductal carcinoma in situ with microinvasion: A meta-analysis.
    Choi B; Jegatheeswaran L; Nakhoul M; Haria P; Srivastava R; Karki S; Lupi M; Patel V; Chakravorty A; Babu E
    Surg Oncol; 2021 Jun; 37():101557. PubMed ID: 33819852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of intraductal carcinoma of the breast.
    Patchefsky AS; Schwartz GF; Finkelstein SD; Prestipino A; Sohn SE; Singer JS; Feig SA
    Cancer; 1989 Feb; 63(4):731-41. PubMed ID: 2536585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of intraductal breast cancer--noncomedo type.
    Griffin A; Frazee RC
    Am Surg; 1993 Feb; 59(2):106-9. PubMed ID: 8386487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast carcinoma in situ.
    Kinne DW; Petrek JA; Osborne MP; Fracchia AA; DePalo AA; Rosen PP
    Arch Surg; 1989 Jan; 124(1):33-6. PubMed ID: 2535929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
    Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
    Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
    Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH
    Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual tumour after biopsy for non-palpable ductal carcinoma in situ of the breast.
    Wobbes T; Tinnemans JG; van der Sluis RF
    Br J Surg; 1989 Feb; 76(2):185-6. PubMed ID: 2539223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
    Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
    Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.